- Home
- VCEL vs PGNY Comparison
VCEL vs PGNY Comparison
Compare VCEL & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- PGNY
- Stock Information
- Founded
- VCEL 1989
- PGNY 2008
- Country
- VCEL United States
- PGNY United States
- Employees
- VCEL N/A
- PGNY N/A
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- PGNY Misc Health and Biotechnology Services
- Sector
- VCEL Health Care
- PGNY Health Care
- Exchange
- VCEL Nasdaq
- PGNY Nasdaq
- Market Cap
- VCEL 2.1B
- PGNY 2.0B
- IPO Year
- VCEL 1997
- PGNY 2019
- Fundamental
- Price
- VCEL $40.12
- PGNY $23.11
- Analyst Decision
- VCEL Strong Buy
- PGNY Buy
- Analyst Count
- VCEL 8
- PGNY 8
- Target Price
- VCEL $62.00
- PGNY $24.00
- AVG Volume (30 Days)
- VCEL 558.9K
- PGNY 1.1M
- Earning Date
- VCEL 07-31-2025
- PGNY 08-07-2025
- Dividend Yield
- VCEL N/A
- PGNY N/A
- EPS Growth
- VCEL 521.85
- PGNY N/A
- EPS
- VCEL 0.05
- PGNY 0.57
- Revenue
- VCEL $238,541,000.00
- PGNY $1,213,181,000.00
- Revenue This Year
- VCEL $23.03
- PGNY $7.09
- Revenue Next Year
- VCEL $24.52
- PGNY $11.68
- P/E Ratio
- VCEL $772.69
- PGNY $41.24
- Revenue Growth
- VCEL 14.80
- PGNY 9.46
- 52 Week Low
- VCEL $34.87
- PGNY $13.39
- 52 Week High
- VCEL $63.00
- PGNY $29.65
- Technical
- Relative Strength Index (RSI)
- VCEL 51.37
- PGNY 54.78
- Support Level
- VCEL $34.87
- PGNY $21.83
- Resistance Level
- VCEL $41.00
- PGNY $23.67
- Average True Range (ATR)
- VCEL 1.77
- PGNY 0.90
- MACD
- VCEL 0.21
- PGNY -0.01
- Stochastic Oscillator
- VCEL 67.83
- PGNY 51.26
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About PGNY Progyny Inc.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.